Navigation Links
Amyotrophic Lateral Sclerosis Association honors Dr. Robert Baloh, M.D.
Date:4/27/2012

LOS ANGELES (April 27, 2012) Robert H. Baloh, MD, PhD, director of Cedars-Sinai Medical Center's Neuromuscular Division, has received the ALS Association Golden West Chapter Commitment to a Cure Award.

Baloh, one of the top doctors and research scientists treating and studying amyotrophic lateral sclerosis (also known as Lou Gehrig's disease), has published groundbreaking discoveries in genetics and molecular biology and is the principal investigator of five projects examining the molecular and cellular basis of ALS and other neuromuscular disorders.

He joined Cedars-Sinai in early 2012 to create one of the most comprehensive ALS treatment and research teams in California, joining Clive Svendsen, PhD, director of the Regenerative Medicine Institute, and Patrick D. Lyden, MD, chair of the Department of Neurology and the Carmen and Louis Warschaw Chair in Neurology.

"I am very honored that the ALS Association chose to recognize our efforts toward developing a cure for ALS. I especially want to acknowledge our patients where ALS runs in their family, whose willingness to work closely with us has been key to our success," Baloh said.

Svendsen said, "We are very proud that Dr. Baloh received this recognition from the ALS Association. He is an outstanding scientist and clinician devoted to solving the mysteries of ALS."

Baloh's research group was one of the first to discover that mutations in the TDP-43 gene cause inherited forms of ALS and frontotemporal lobar degeneration, a type of dementia that can accompany ALS. He also led studies that in 2009 produced the first mouse model of ALS based on the TDP-43 gene. The first new ALS mouse model in 14 years, it is employed by researchers worldwide to study the disease.

Baloh earned his PhD and MD degrees at Washington University School of Medicine in St. Louis and is board certified in both neurology and neuromuscular medicine. Two of his current research projects are funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke and others are supported by grants from the Muscular Dystrophy Association and Burroughs Wellcome Foundation.  

Even as Baloh and his colleagues seek cures, they work to improve their patients' quality of life. Cedars-Sinai's multidisciplinary ALS clinic recently became the first West Coast site and one of only three nationwide providing an implanted breathing-assist device for ALS patients suffering chronic hypoventilation, the inability to take enough air into the lungs. The device can be used in a hospital, at a rehabilitation center or at home, and unlike an external ventilator, the system is silent.


'/>"/>

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Contralateral prophylactic mastectomy offers limited gains for breast cancer patients
2. War on cancer produces collateral damage to the heart
3. Gay mens bilateral brains better at remembering faces: York U study
4. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
5. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
6. Experimental Pill for Multiple Sclerosis Shows Promise
7. Experimental Pill May Ease Multiple Sclerosis Disability
8. Diabetes drug halts atherosclerosis progression in HIV-infected patients
9. Researchers discover new culprit in atherosclerosis
10. Multiple Sclerosis May Cause Changes in Thalamus: Study
11. Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... "FCPX Overlay Glare is a tool that utilizes light found ... or complicated compositing," said Christina Austin - CEO of Pixel Film Studios. , ... lights that simulates the look of a glare. Just drag and drop to ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... been featured in SuperbCrew magazine, a leading online tech news platform connecting technology ... now featured on SuperbCrew.com, explores the state of enterprise mobility security today, and ...
(Date:12/5/2016)... ... , ... “Epilepsy Awareness,” which can be found at the ... about epilepsy, bearing down on the social stigma and lack of public education ... within their lifetime. With such a large percentage of people affected, it’s critically ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders are equal ... Castlewood Treatment Centers has always been to promote the power of recovery, and ... possible. In that spirit, Castlewood has announced two new hires, both Outreach Directors ...
(Date:12/5/2016)... Shrewsbury, PA (PRWEB) , ... December 05, 2016 , ... ... of necessity for the betterment of both the smaller rider and the horse. Smaller ... performance. The Saddle Sidekick is designed to fit over a properly fitted western saddle ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)... -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ), the ... and manufacturing data that support SB-525, its gene therapy program ... of the American Society of Hematology (ASH) being held in ... 2016. "We have developed an improved gene therapy ... highly competitive, and we remain on track to file an ...
(Date:12/5/2016)... Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., a ... data from two Phase I trials evaluating its ... 58th annual meeting of the American Society of ... . The two datasets show encouraging efficacy ... leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), ...
Breaking Medicine Technology: